Tag: GLP-1 drugs

Global Companies

Novo Nordisk’s Bold Restructuring: Job Cuts and Strategic Shift

Novo Nordisk axes 9,000 jobs and slashes guidance as GLP-1 drugs face competition. Can the new CEO turn the tide...

10/09/2025

4 views

Read More

Global Markets

How Weight Loss Drugs Are Transforming Economy

Weight loss drugs like Wegovy are changing more than waistlines—they’re reshaping economies. From food to travel, their impact is huge....

26/08/2025

3 views

Read More

Market News

Can Weight Loss Drugs Transform Your Dating Life?

Could weight loss drugs like Wegovy boost your dating game? Discover how health changes spark confidence and connection, but what’s...

05/08/2025

2 views

Read More

Market News

What’s Fueling Tuesday’s Stock Surge and Lilly’s Defense

What's behind Tuesday's stock surge? From AI infrastructure to Eli Lilly's GLP-1 defense, uncover the market movers. Click to find...

03/06/2025

0 views

Read More

Growth Picks

Why Eli Lilly Stock Is a Smart Buy Now

Eli Lilly's stock is down 20%, but its GLP-1 dominance and new oral pill could spark a rebound. Is now...

22/05/2025

0 views

Read More

Market News

Cigna Slashes Costs for Weight Loss Drugs

Cigna’s new deal makes weight loss drugs like Wegovy and Zepbound more affordable with $200 copay caps. How will this...

21/05/2025

0 views

Read More

Risk Management

Why Eli Lilly Stock Faces Risks In 2025

Eli Lilly’s stock is soaring, but HSBC’s downgrade hints at trouble ahead. High valuations and fierce competition could spell danger....

28/04/2025

50 views

Read More

Global Companies

Weight-Loss Drug Surge Shakes Up Pharma Stocks

A new weight-loss pill is shaking up pharma stocks, with one company soaring and rivals sinking. What's next for this...

17/04/2025

6 views

Read More